163 related articles for article (PubMed ID: 28239238)
1. Cytokine Imbalance as a Common Mechanism in Both Psoriasis and Rheumatoid Arthritis.
Tan Y; Qi Q; Lu C; Niu X; Bai Y; Jiang C; Wang Y; Zhou Y; Lu A; Xiao C
Mediators Inflamm; 2017; 2017():2405291. PubMed ID: 28239238
[TBL] [Abstract][Full Text] [Related]
2. The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis.
Cerezo LA; Remáková M; Tomčik M; Gay S; Neidhart M; Lukanidin E; Pavelka K; Grigorian M; Vencovský J; Šenolt L
Rheumatology (Oxford); 2014 Aug; 53(8):1520-6. PubMed ID: 24643522
[TBL] [Abstract][Full Text] [Related]
3. Down-regulating peroxisome proliferator-activated receptor-gamma coactivator-1 beta alleviates the proinflammatory effect of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting extracellular signal-regulated kinase, p38 and nuclear factor-kappaB activation.
Zhou JJ; Ma JD; Mo YQ; Zheng DH; Chen LF; Wei XN; Dai L
Arthritis Res Ther; 2014 Oct; 16(5):472. PubMed ID: 25367151
[TBL] [Abstract][Full Text] [Related]
4. Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis.
Zheng W; Li R; Pan H; He D; Xu R; Guo TB; Guo Y; Zhang JZ
Arthritis Rheum; 2009 Jul; 60(7):1957-65. PubMed ID: 19565503
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of gene expression profiles identifies transcription factors potentially involved in psoriasis pathogenesis.
Zeng F; Liu H; Lu D; Liu Q; Chen H; Zheng F
J Cell Biochem; 2019 Aug; 120(8):12582-12594. PubMed ID: 30825251
[TBL] [Abstract][Full Text] [Related]
6. The Crosstalk of Pathways Involved in Immune Response Maybe the Shared Molecular Basis of Rheumatoid Arthritis and Type 2 Diabetes.
Niu X; Lu C; Xiao C; Ge N; Jiang M; Li L; Bian Y; Xu G; Bian Z; Zhang G; Lu A
PLoS One; 2015; 10(8):e0134990. PubMed ID: 26252209
[TBL] [Abstract][Full Text] [Related]
7. Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
Tuller T; Atar S; Ruppin E; Gurevich M; Achiron A
Genes Immun; 2013 Mar; 14(2):67-82. PubMed ID: 23190644
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of IL-23p19 expression in rheumatoid arthritis synovial fibroblasts by IL-17 through PI3-kinase-, NF-kappaB- and p38 MAPK-dependent signalling pathways.
Kim HR; Cho ML; Kim KW; Juhn JY; Hwang SY; Yoon CH; Park SH; Lee SH; Kim HY
Rheumatology (Oxford); 2007 Jan; 46(1):57-64. PubMed ID: 16772307
[TBL] [Abstract][Full Text] [Related]
9. The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease.
Ochaion A; Bar-Yehuda S; Cohen S; Barer F; Patoka R; Amital H; Reitblat T; Reitblat A; Ophir J; Konfino I; Chowers Y; Ben-Horin S; Fishman P
Cell Immunol; 2009; 258(2):115-22. PubMed ID: 19426966
[TBL] [Abstract][Full Text] [Related]
10. Amplification of the synovial inflammatory response through activation of mitogen-activated protein kinases and nuclear factor kappaB using ligation of CD40 on CD14+ synovial cells from patients with rheumatoid arthritis.
Harigai M; Hara M; Kawamoto M; Kawaguchi Y; Sugiura T; Tanaka M; Nakagawa M; Ichida H; Takagi K; Higami-Ohsako S; Shimada K; Kamatani N
Arthritis Rheum; 2004 Jul; 50(7):2167-77. PubMed ID: 15248214
[TBL] [Abstract][Full Text] [Related]
11. Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes.
Xu H; He Y; Yang X; Liang L; Zhan Z; Ye Y; Yang X; Lian F; Sun L
Rheumatology (Oxford); 2007 Jun; 46(6):920-6. PubMed ID: 17314215
[TBL] [Abstract][Full Text] [Related]
12. TACE-dependent amphiregulin release is induced by IL-1β and promotes cell invasion in fibroblast-like synoviocytes in rheumatoid arthritis.
Liu FL; Wu CC; Chang DM
Rheumatology (Oxford); 2014 Feb; 53(2):260-9. PubMed ID: 24196392
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
[TBL] [Abstract][Full Text] [Related]
14. Increased nuclear factor-kappaB activation in peripheral blood monocytes of patients with rheumatoid arthritis is mediated primarily by tumor necrosis factor-alpha.
Dichamp I; Bourgeois A; Dirand C; Herbein G; Wendling D
J Rheumatol; 2007 Oct; 34(10):1976-83. PubMed ID: 17896809
[TBL] [Abstract][Full Text] [Related]
15. MDM2 promotes rheumatoid arthritis via activation of MAPK and NF-κB.
Zhang L; Luo J; Wen H; Zhang T; Zuo X; Li X
Int Immunopharmacol; 2016 Jan; 30():69-73. PubMed ID: 26655743
[TBL] [Abstract][Full Text] [Related]
16. Curcumin inhibits osteoclastogenic potential in PBMCs from rheumatoid arthritis patients via the suppression of MAPK/RANK/c-Fos/NFATc1 signaling pathways.
Shang W; Zhao LJ; Dong XL; Zhao ZM; Li J; Zhang BB; Cai H
Mol Med Rep; 2016 Oct; 14(4):3620-6. PubMed ID: 27572279
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-8 induction via NF-kappaB, p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1/2 pathways in human peripheral blood mononuclear cells by Alloiococcus otitidis.
Harimaya A; Koizumi J; Fujii N; Himi T
Int J Pediatr Otorhinolaryngol; 2007 Sep; 71(9):1465-70. PubMed ID: 17629956
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level.
Madi L; Cohen S; Ochayin A; Bar-Yehuda S; Barer F; Fishman P
J Rheumatol; 2007 Jan; 34(1):20-6. PubMed ID: 17216675
[TBL] [Abstract][Full Text] [Related]
19. Antiinflammatory effect of Rho kinase blockade via inhibition of NF-kappaB activation in rheumatoid arthritis.
He Y; Xu H; Liang L; Zhan Z; Yang X; Yu X; Ye Y; Sun L
Arthritis Rheum; 2008 Nov; 58(11):3366-76. PubMed ID: 18975348
[TBL] [Abstract][Full Text] [Related]
20. (E)-3-(3,4-Dimethoxyphenyl)-1-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)prop-2-en-1-one ameliorates the collagen-arthritis via blocking ERK/JNK and NF-κB signaling pathway.
Li X; Peng F; Xie C; Wu W; Han X; Chen L
Int Immunopharmacol; 2013 Dec; 17(4):1125-33. PubMed ID: 24135236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
